Ureteral Diseases
3 drugs in active Ureteral Diseases trials · Updated 19 Nov 2026
Furthest along
3 in Phase 1
Next Phase 3 result
None yet
Drugs
3
In active trials, any stage
Trials
3 active
2 sub-diseases included
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Eli Lilly · Public LLY |
Phase 1 | Mar 2027Phase 1 trial completes | ||
| Next date | Mar 2027 · Phase 1 trial completes | ||||
| Also tested for | Metastatic Solid Tumor, Recurrent Solid Tumor and 12 more | ||||
| Open drug page | |||||
— |
Eli Lilly · Public LLY |
Phase 1 | May 2027Phase 1 trial completes | ||
| Next date | May 2027 · Phase 1 trial completes | ||||
| Also tested for | Metastatic Solid Tumor, Recurrent Solid Tumor and 12 more | ||||
| Open drug page | |||||
Tyrosine kinase inhibitor |
Eli Lilly · Public LLY |
Phase 1 | Jun 2027Phase 1 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Urinary Bladder Neoplasms, Neoplasm Metastasis and 1 more | ||||
| Open drug page | |||||
Included2
| Sub-disease | Drugs | Active trialsTrials |
|---|---|---|
| Ureteral Neoplasms | 3 | 3 |
1 more with no active trials: Ureterolithiasis
How trials write it2
The conditions trials list that we place on Ureteral Diseases itself, with their active trials
Ureter Injury 4Injury of Ureter During Surgery (Disorder) 1
About
- Summary
- 3 drugs are in active Ureteral Diseases trials. Updated 19 Nov 2026.
- Registry term
- Ureteral Diseases
- Counts
- Active trials the registry tags with the term or a term under it, at any stage. A search also reads trial titles and drug names, so its counts differ.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026